Robert Redfield Onconova Therapeutics, Inc. (ONTX) insider trading activity

ONTX Quotes by TradingView

Robert Redfield is Chief Medical Officer of Onconova Therapeutics, Inc.. Currently has a direct ownership of 113,919 shares of ONTX, which is worth approximately $67,212. The most recent transaction as insider was on Dec 12, 2025, when has been sold 16,419 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 114K
16.84% 3M change
16.84% 12M change
Total Value Held $67,212

Robert Redfield Transaction History

Date Transaction Value Shares Traded Shares Held Form
Dec 12 2025
BUY
Grant, award, or other acquisition
-
16,419 Added 12.6%
113,919 Common Stock
Apr 01 2024
BUY
Grant, award, or other acquisition
-
97,500 Added 50.0%
97,500 Common Stock
RR

Robert Redfield

Chief Medical Officer
Newtown, PA

Track Institutional and Insider Activities on ONTX

Follow Onconova Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ONTX shares.

Notify only if

Insider Trading

Get notified when an Onconova Therapeutics, Inc. insider buys or sells ONTX shares.

Notify only if

News

Receive news related to Onconova Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on ONTX